![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » EU Signs COVID-19 Vaccine Supply Deal With Sanofi/GSK
EU Signs COVID-19 Vaccine Supply Deal With Sanofi/GSK
![](https://www.fdanews.com/ext/resources/test/Device_Images6/EuropeanCommissiononFloor.gif?t=1540854777&width=430)
The European Commission has signed a contract with Sanofi and GlaxoSmithKline (GSK) for 300 million doses of their COVID-19 vaccine for the European Union.
The EU will provide upfront funding to support the scale-up of Sanofi’s and GSK’s manufacturing capabilities in Europe. The contract allows for EU member states to donate doses to lower- and middle-income countries.
The commission has previously signed a contract with AstraZeneca for up to 400 million doses of its vaccine and is in ongoing discussions with other companies for supply deals.
Upcoming Events
-
21Oct